Last reviewed · How we verify
Dymanthine (dimantine)
Dymanthine (generic name: dimantine) is a dimantine drug. It is currently in unknown development.
Dymanthine works by interacting with a specific molecular target to produce a therapeutic effect.
Dymanthine is a small molecule with the chemical name N,N-dimethyl-1-octadecanamine. It is also known by other names, including Dimantina, Dimantine, and Dimethyl Stearamine.
At a glance
| Generic name | dimantine |
|---|---|
| Drug class | dimantine |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine Dymanthine as a key that fits into a lock on a cell's surface. When it binds to this lock, it triggers a series of events that ultimately help to treat a particular disease or condition. This process is highly specific and helps to minimize side effects.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dymanthine CI brief — competitive landscape report
- Dymanthine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Dymanthine
What is Dymanthine?
How does Dymanthine work?
What is the generic name of Dymanthine?
What drug class is Dymanthine in?
What development phase is Dymanthine in?
Related
- Drug class: All dimantine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing